PE20091735A1 - Derivados del acido 4-dimetilaminobutirico - Google Patents
Derivados del acido 4-dimetilaminobutiricoInfo
- Publication number
- PE20091735A1 PE20091735A1 PE2009000570A PE2009000570A PE20091735A1 PE 20091735 A1 PE20091735 A1 PE 20091735A1 PE 2009000570 A PE2009000570 A PE 2009000570A PE 2009000570 A PE2009000570 A PE 2009000570A PE 20091735 A1 PE20091735 A1 PE 20091735A1
- Authority
- PE
- Peru
- Prior art keywords
- dimethylamine
- compounds
- octanoylamine
- difluor
- benzyloxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DEL ACIDO 4-DIMETILAMINOBUTIRICO DE FORMULA (I) DONDE A1 ES NH O UN ENLACE; A2 ES UN ENLACE, O, O(CH2)2O, S, SO2, ENTRE OTROS; m ES DE 2 A 11; n ES DE 0 A 5; R1 ES FENILO, NAFTILO, PIRIDILO, TIENILO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS CON ALQUILO INFERIOR, HALOGENO, ALCOXI INFERIOR, ENTRE OTROS SUSTITUYENTES. SON COMPUESTOS PREFERIDOS: ACIDO (R)-3-[8-(3,4-DIFLUOR-BENCILOXI)-OCTANOILAMINO]-4-DIMETILAMINO-BUTIRICO, ACIDO (R)-3-[8-(2,5-DIFLUOR-BENCILOXI)-OCTANOILAMINO]-4-DIMETILAMINO-BUTIRICO, ACIDO (R)-4-DIMETILAMINO-3-[8-(2-FENOXI-ETOXI)-OCTANOIL-AMINO]-BUTIRICO, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA CARNITINA-PALMITOIL-TRANSFERASA (CPT) SIENDO UTILES EN EL TRATAMIENTO DE DIABETES, OBESIDAD, HIPERLIPIDEMIA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08155323 | 2008-04-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20091735A1 true PE20091735A1 (es) | 2009-11-13 |
Family
ID=40897585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2009000570A PE20091735A1 (es) | 2008-04-29 | 2009-04-27 | Derivados del acido 4-dimetilaminobutirico |
Country Status (18)
Country | Link |
---|---|
US (2) | US8344027B2 (es) |
EP (1) | EP2268606B1 (es) |
JP (1) | JP5474047B2 (es) |
KR (1) | KR101225223B1 (es) |
CN (1) | CN101952243B (es) |
AR (1) | AR073842A1 (es) |
AU (1) | AU2009242240B2 (es) |
BR (1) | BRPI0911159A2 (es) |
CA (1) | CA2722087C (es) |
CL (1) | CL2009001006A1 (es) |
ES (1) | ES2507089T3 (es) |
IL (1) | IL206524A0 (es) |
MX (1) | MX2010008196A (es) |
PE (1) | PE20091735A1 (es) |
RU (1) | RU2474573C2 (es) |
TW (1) | TWI369344B (es) |
WO (1) | WO2009132978A1 (es) |
ZA (1) | ZA201005321B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009132979A1 (en) * | 2008-04-29 | 2009-11-05 | F. Hoffmann-La Roche Ag | 4-trimethylammonio-butyrates as cpt2 inhibitors |
KR101225223B1 (ko) | 2008-04-29 | 2013-01-22 | 에프. 호프만-라 로슈 아게 | 4-다이메틸아미노부티르산 유도체 |
FR2951448B1 (fr) * | 2009-10-15 | 2012-09-07 | Centre Nat Rech Scient | Synthese de polyurethane par autocondensation |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CN105859658A (zh) * | 2016-05-12 | 2016-08-17 | 青岛大学 | (r)-2-羟基-n-((2s,3s)-2-((r,e)-1-羟基十五烷-4-烯-1-基) 氧杂环-3-基)二十四烷酸胺及其制备方法 |
CN115304569A (zh) * | 2022-09-14 | 2022-11-08 | 浙江世佳科技股份有限公司 | 一种以4-甲基苯磺酸吡啶鎓为催化剂的端醇羟基保护方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3476656D1 (en) | 1983-05-25 | 1989-03-16 | Takeda Chemical Industries Ltd | Derivatives of beta-amino-gamma-trimethylammonio-butyrate, their production and use |
US4632925A (en) | 1985-10-07 | 1986-12-30 | Hoffmann-La Roche Inc. | N-substituted diphenylpiperidines and antiobesity use thereof |
IT1299266B1 (it) | 1998-05-15 | 2000-02-29 | Sigma Tau Ind Farmaceuti | Inibitori reversibili della carnitina palmitoil trasferasi |
ITMI20010395A1 (it) * | 2001-02-27 | 2002-08-27 | Dompe Spa | Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate |
ITMI20040230A1 (it) * | 2004-02-12 | 2004-05-12 | Defiante Farmaceutica Lda | Composti ad attivita' antitumorale |
ITRM20050090A1 (it) * | 2005-03-02 | 2006-09-03 | Sigma Tau Ind Farmaceutiche Riunite Spa | Derivati dell'acido ammino-butanoico inibitore della cpt. |
RU2309144C2 (ru) * | 2005-03-25 | 2007-10-27 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств |
BRPI0715084A2 (pt) * | 2006-08-02 | 2013-03-12 | Sigma Tau Ind Farmaceuthiche Riunite S P A | derivados de 4-trimetilamânio-3-aminobutirato e 4-trimetilfosfânico-3-aminobutirato como inibidores de cpt |
US8410150B2 (en) * | 2007-03-09 | 2013-04-02 | University Health Network | Inhibitors of carnitine palmitoyltransferase and treating cancer |
KR101225223B1 (ko) | 2008-04-29 | 2013-01-22 | 에프. 호프만-라 로슈 아게 | 4-다이메틸아미노부티르산 유도체 |
-
2009
- 2009-04-20 KR KR1020107024228A patent/KR101225223B1/ko not_active IP Right Cessation
- 2009-04-20 MX MX2010008196A patent/MX2010008196A/es active IP Right Grant
- 2009-04-20 ES ES09738022.4T patent/ES2507089T3/es active Active
- 2009-04-20 CN CN200980105617.7A patent/CN101952243B/zh not_active Expired - Fee Related
- 2009-04-20 AU AU2009242240A patent/AU2009242240B2/en not_active Ceased
- 2009-04-20 RU RU2010148532/04A patent/RU2474573C2/ru not_active IP Right Cessation
- 2009-04-20 BR BRPI0911159A patent/BRPI0911159A2/pt active Search and Examination
- 2009-04-20 JP JP2011505469A patent/JP5474047B2/ja not_active Expired - Fee Related
- 2009-04-20 CA CA2722087A patent/CA2722087C/en not_active Expired - Fee Related
- 2009-04-20 EP EP09738022.4A patent/EP2268606B1/en not_active Not-in-force
- 2009-04-20 WO PCT/EP2009/054635 patent/WO2009132978A1/en active Application Filing
- 2009-04-27 AR ARP090101488A patent/AR073842A1/es not_active Application Discontinuation
- 2009-04-27 PE PE2009000570A patent/PE20091735A1/es not_active Application Discontinuation
- 2009-04-27 TW TW098113900A patent/TWI369344B/zh not_active IP Right Cessation
- 2009-04-28 US US12/430,934 patent/US8344027B2/en not_active Expired - Fee Related
- 2009-04-28 CL CL2009001006A patent/CL2009001006A1/es unknown
-
2010
- 2010-06-21 IL IL206524A patent/IL206524A0/en unknown
- 2010-07-26 ZA ZA2010/05321A patent/ZA201005321B/en unknown
-
2012
- 2012-07-24 US US13/556,250 patent/US20120289554A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101952243B (zh) | 2014-07-16 |
TW200946106A (en) | 2009-11-16 |
JP5474047B2 (ja) | 2014-04-16 |
KR20100127306A (ko) | 2010-12-03 |
AU2009242240A1 (en) | 2009-11-05 |
RU2474573C2 (ru) | 2013-02-10 |
CN101952243A (zh) | 2011-01-19 |
CL2009001006A1 (es) | 2010-06-04 |
AU2009242240B2 (en) | 2011-09-22 |
US20120289554A1 (en) | 2012-11-15 |
WO2009132978A1 (en) | 2009-11-05 |
CA2722087A1 (en) | 2009-11-05 |
CA2722087C (en) | 2013-07-09 |
ZA201005321B (en) | 2011-04-28 |
JP2011518205A (ja) | 2011-06-23 |
EP2268606B1 (en) | 2014-08-06 |
EP2268606A1 (en) | 2011-01-05 |
US20090270505A1 (en) | 2009-10-29 |
ES2507089T3 (es) | 2014-10-14 |
MX2010008196A (es) | 2010-08-11 |
AR073842A1 (es) | 2010-12-09 |
BRPI0911159A2 (pt) | 2015-10-06 |
IL206524A0 (en) | 2010-12-30 |
US8344027B2 (en) | 2013-01-01 |
TWI369344B (en) | 2012-08-01 |
RU2010148532A (ru) | 2012-06-10 |
KR101225223B1 (ko) | 2013-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200900658A1 (ru) | Производные индазолилэфиров или -амидов для лечения расстройств, опосредованных глюкокортиодными рецепторами | |
PE20090226A1 (es) | PIRROLIDINAMIDAS SUSTITUIDAS COMO INHIBIDORES DEL FACTOR Xa Y SU PREPARACION | |
PE20091735A1 (es) | Derivados del acido 4-dimetilaminobutirico | |
PE20120690A1 (es) | Derivados de 5-fluoropirimidinona | |
PE20120691A1 (es) | Derivados de n1-sulfonil-5-fluoropirimidinona | |
EA201190235A1 (ru) | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 | |
EA201001682A1 (ru) | Производные фенил- и бензодиоксинилзамещенных индазолов | |
PE20091843A1 (es) | Inhibidores de catepsina c | |
EA201000050A1 (ru) | Замещенные бициклолактамные соединения | |
PE20141322A1 (es) | Ciclopropilaminas como inhibidores de desmetilasa 1 especifica de lisina | |
CY1112011T1 (el) | Παραγωγα αζαδικυκλο (3.1.0) εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης | |
EA201290416A1 (ru) | Новые спиропиперидиновые соединения | |
EA201001407A1 (ru) | Производные хиноксалинона в качестве стимуляторов секреции инсулина, способы их получения и их применение для лечения диабета | |
EA200601295A1 (ru) | Производные 1,3-диоксана и их аналоги, применимые для лечения i.a. ожирения и диабета | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
ATE538100T1 (de) | Aminotetrahydroindazoloessigsäuren | |
PE20142282A1 (es) | Nuevos derivados de aril-quinolina | |
PE20140968A1 (es) | Derivados de benzamida sustituida | |
CY1115800T1 (el) | Παραγωγα της 3-(ετεροαρυλο-αμινο)-1,2,3,4-τετραϋδρo-9η-καρβαζολης και η χρηση τους ως ρυθμιστες των υποδοχεων της προσταγλανδινης d2 | |
PE20120810A1 (es) | Compuestos derivados de 5-ciano-2-(feniltio)bencensulfonamida como antagonistas de ccr3 | |
CY1109569T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
DE602007001463D1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
EA201001087A1 (ru) | Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
EA200901474A1 (ru) | Соли [4-(6-фтор-7-метиламино-2,4-диоксо-1,4-дигидро-2н-хиназолин-3-ил)фенил]-5-хлортиофен-2-илсульфонилмочевины в различных кристаллических формах и фармацевтические композиции на их основе | |
EA201001405A1 (ru) | Стимуляторы секреции инсулина - производные пиридопиразинонов, способы их получения и их применение для лечения диабета |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |